Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that at the
Annual General Meeting (“AGM”) held earlier today, all resolutions were duly passed.
The voting results of the AGM were as follows:
| In Favour | Against | Withheld | |||
| Resolution | Votes | % | Votes | % | Votes |
| 1 | 62,212,695 | 100 | 0 | 0 | 0 |
| 2 | 62,212,118 | 100 | 577 | 0 | 0 |
| 3 | 62,212,545 | 100 | 0 | 0 | 150 |
| 4 | 52,879,826 | 85 | 9,332,869 | 15 | 0 |
| 5 | 51,490,878 | 83 | 10,720,067 | 17 | 1,750 |
Sara Barrington, CEO
Julian Baines, Chairman
www.vericidx.com
Via Walbrook PR
N+1 Singer (Nominated Adviser & Broker)
Aubrey Powell / Kailey Aliyar / Tom Salvesen
Tel: 020 7496 3000
Walbrook PR Limited
Paul McManus / Sam Allen
Tel: 020 7933 8780 or vericidx@walbrookpr.com
Mob: 07980 541 893 / 07748 651 727
